We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
BJs Wholesale Club
BJ
$11.7B
| $1.83M | ﹤0.01% |
29,040
-23,059
| -44% | -$1.59M |
|
977
Camping World
CWH
$355M
| $1.83M | ﹤0.01% |
+60,772
| New | +$1.53M |
|
978
Edwards Lifesciences
EW
$51.5B
| $1.83M | ﹤0.01% |
19,373
+6,485
| +50% | +$564K |
|
979
Carlisle Companies
CSL
$12.6B
| $1.82M | ﹤0.01% |
7,092
-11,499
| -62% | -$2.55M |
|
980
Genco Shipping & Trading
GNK
$1.2B
| $1.81M | ﹤0.01% |
128,765
-86,662
| -40% | -$1.25M |
|
981
TriCo Bancshares
TCBK
$1.71B
| $1.8M | ﹤0.01% |
54,222
-271
| -0.5% | -$9.65K |
|
982
Xerox
XRX
$457M
| $1.8M | ﹤0.01% |
120,666
+91,436
| +313% | +$1.34M |
|
983
Caesars Entertainment
CZR
$6.05B
| $1.79M | ﹤0.01% |
35,114
-6,608
| -16% | -$300K |
|
984
Seacoast Banking Corp of Florida
SBCF
$3.27B
| $1.79M | ﹤0.01% |
80,852
-15,065
| -16% | -$327K |
|
985
Cars.com
CARS
$617M
| $1.78M | ﹤0.01% |
89,674
-33
| -0% | -$621 |
|
986
Diodes
DIOD
$4.12B
| $1.76M | ﹤0.01% |
19,021
| – | – |
|
987
Watsco Inc
WSO
$12.5B
| $1.76M | ﹤0.01% |
4,610
+289
| +7% | +$98K |
|
988
Align Technology
ALGN
$10.7B
| $1.76M | ﹤0.01% |
4,967
-1,573
| -24% | -$501K |
|
989
J.M. Smucker
SJM
$13.2B
| $1.75M | ﹤0.01% |
11,862
+47
| +0.4% | +$7.17K |
|
990
Bioceres Crop Solutions
BIOX
$24.6M
| – | – |
0
| – | – |
|
991
Allegiant Air
ALGT
$2.15B
| $1.73M | ﹤0.01% |
13,710
-361
| -3% | -$37.8K |
|
992
Conduent
CNDT
$252M
| $1.73M | ﹤0.01% |
508,797
-923
| -0.2% | -$3.02K |
|
993
Peapack-Gladstone Financial
PGC
$798M
| $1.72M | ﹤0.01% |
63,528
-1,041
| -2% | -$28.5K |
|
994
ON Semiconductor
ON
$25.9B
| $1.72M | ﹤0.01% |
18,185
+1,439
| +9% | +$119K |
|
995
Super Micro Computer
SMCI
$24.2B
| $1.71M | ﹤0.01% |
68,680
+7,590
| +12% | +$127K |
|
996
InnovAge Holding
INNV
$1.48B
| $1.7M | ﹤0.01% |
226,509
-6,545
| -3% | -$44.9K |
|
997
Voya Financial
VOYA
$9.09B
| $1.69M | ﹤0.01% |
23,563
+2,468
| +12% | +$177K |
|
998
Preferred Bank
PFBC
$1.26B
| $1.69M | ﹤0.01% |
30,644
-224
| -0.7% | -$11.3K |
|
999
Blackbaud
BLKB
$2.03B
| $1.67M | ﹤0.01% |
23,485
+16,939
| +259% | +$1.19M |
|
1000
First Bancorp
FBNC
$2.59B
| $1.67M | ﹤0.01% |
56,020
-2,352
| -4% | -$74.4K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.